Add to Favorites Newsroom RSS Share
Tampa, FL USA

Our News on Newswise

New CAR T Case Study Shows Promise in Acute Myeloid Leukemia

TAMPA, Fla. – Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient’s own immune...
9-May-2018 10:00 AM EDT Add to Favorites

Moffitt Cancer Center Awarded $900,000 to Study Rare Form of Melanoma

TAMPA, Fla. – May is Skin Cancer Awareness Month. More than 5 million people in the United States are diagnosed with the disease each year, making it the most common cancer in our country. While prevention and screening are keys to driving down...
3-May-2018 1:05 PM EDT Add to Favorites

Florida Cancer Centers Awarded $1.36 Million to Fight Pancreatic Cancer

The Florida Department of Health’s James and Esther King Biomedical Research Program has armed Moffitt Cancer Center, University of Florida (UF) Health Cancer Center – Gainesville, Sylvester Comprehensive Cancer Center at the University of Miami...
1-May-2018 11:50 AM EDT Add to Favorites

Moffitt Researchers Use Mathematical Modeling and Evolutionary Principles To Show Importance of Basing Treatment Decisions on Tumor Responses

TAMPA, Fla. – Cancer patients are commonly treated with the maximum dose they are able to withstand that does not cause too many toxic side effects.  However, many patients become resistant to these treatments and develop cancer recurrence. ...
30-Apr-2018 11:05 AM EDT Add to Favorites

Drug Combination Targeting Heat Shock Protein 90 and BRAF is Safe and Effective in Advanced Melanoma Patients

TAMPA, Fla. – Patients with advanced or metastatic melanoma have been able to live longer cancer-free lives because of several new therapies approved over the last decade, such as BRAF and MEK inhibitors. However, despite the success of these...
19-Apr-2018 10:05 AM EDT Add to Favorites

Mathematical Modeling Offers New Way to Understand Variable Responses to Targeted Therapy

Cancer therapies that target a specific protein have improved outcomes for patients. However, many patients eventually develop resistance to these targeted therapies and their cancer comes back. It is believed that differences among tumor cells, or...
3-Apr-2018 10:05 AM EDT Add to Favorites

Screening High-Risk Individuals Can Reduce Multiple Myeloma Mortality

TAMPA, Fla. – Multiple myeloma is a rare incurable disease that is diagnosed in more than 30,000 people each year in the United States.  Only half of patients with multiple myeloma are expected to survive five years after their diagnosis. Moffitt...
27-Mar-2018 8:05 AM EDT Add to Favorites

Moffitt Researchers Use Single-Cell Imaging and Mathematical Modeling to Determine Effective Drug Properties

Drug therapies that target a specific molecule have changed the way patients are treated for cancer and greatly improved survival rates. However, some patients do not respond to these therapies because the drug is not reaching the tumor cells...
13-Mar-2018 9:00 AM EDT Add to Favorites

see all news

Our Experts on Newswise


Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

see all experts

Our YouTube Videos

Chat now!